Key points from article :
Scientists are developing new therapies that focus on editing RNA instead of DNA (like CRISPR).
RNA editing involves changing messenger RNA (mRNA), which carries instructions for making proteins, potentially fixing problems caused by genetic diseases.
Two RNA-editing therapies have recently been approved for clinical trials, making them the first of their kind to reach this stage of testing.
Researchers believe RNA editing could be safer and more versatile than DNA editing techniques, but it also comes with technical challenges.
The approval of clinical trials shows that RNA editing is a promising area of research with the potential to revolutionize how we treat genetic diseases.
This article was published in the journal Nature.
